Apply to trial NCT07075471

A few quick questions so the study team can decide if you might be a fit.

Recruiting

Tenosynovial Giant Cell Tumor (TGCT) Real-World Participant Experience With Vimseltinib

The goal of this observational study is to better understand real-world use of vimseltinib, treatment patterns, and health-related quality of life in participants treated with vimseltinib for TGCT. This study will collect data in an observational disease registry involving no intervention to the participants and will not influence standard medical care or impact treatment decisions for participants.

How this works

Answer a few questions
About 5 to 10 minutes. Skip-friendly where possible.
We connect you with the study team
When a site picks up your application, we introduce you to their team directly — with you on the thread.
The team reaches out to schedule screening
Usually within a few business days, via the contact you give.

EmailWe save your progress under this email and copy you when we connect you with the study team.

I agree that Hipa.ai may share my application — my name, contact details, and my answers, including health information — with the official study team for this trial so they can review my responses and contact me.

By continuing, you agree to our terms of service.

Tenosynovial Giant Cell Tumor (TGCT) Real-World Participant Experience With Vimseltinib

How this works

Answer a few questions

We connect you with the study team

The team reaches out to schedule screening